Company: HCTI
Filing Date: 2025-05-09
Form Type: S-1/A
Source: 0001213900-25-041190
Chunk: 27

Company: Healthcare Triangle, Inc.
Filing Date: 2025-05-09
Form: S-1/A
Chunk 27
---
 1,483,809,885 shares of Common Stock, consisting of (i) up to
7,017,429 shares of Common Stock purchased from us by the selling stockholders as part of the Units; (ii) up to 29,173,056 shares of
Common Stock that may be issued to the selling stockholders if they fully exercise the Pre-Funded Warrants; (iii) 361,904,850 shares
of Common Stock that may be issued to the selling stockholders if they fully exercise the Series A Warrants at the floor price of $0.084
per share and (iv) 1,085,714,550 shares of Common Stock that may be issued to the selling stockholders if they fully exercise the Series
B Warrants using the “zero exercise price option” as provided for in the Series B Warrants and prior to such exercise, the
exercise price for all of the shares underlying the Series B Warrants is reset to the floor price of $0.084 per share. The shares of
Common Stock covered by this prospectus will be issued in reliance on exemptions from registration provided by Section 4(a)(2) of the
Securities Act and Rule 506(b) promulgated thereunder.

We are registering the
shares of Common Stock to permit the selling stockholders to offer these shares for resale from time to time and to satisfy our obligations
in connection with the Registration Rights Agreement. The selling stockholders are investors who have had no position, office, or other
material relationship (other than as a purchaser of securities) with us or any of our affiliates within the past three years. Our knowledge
is based on information provided by selling stockholder questionnaires in connection with the filing of this prospectus.

The table below lists
the selling stockholders and information regarding the ownership of the shares of Common Stock held by each such selling stockholder.
The number of shares of our Common Stock beneficially owned has been determined in accordance with Rule 13d-3 under the Exchange Act (“Rule
13d-3”), and such information is not necessarily indicative of beneficial ownership for any other purpose. Under Rule 13d-3, beneficial
ownership includes any shares as to which a selling stockholder has sole or shared voting power or investment power and also any shares
which that selling stockholder has the right to acquire within 60 days of the date of this prospectus through the exercise of any stock
options or warrants. The number of shares beneficial